Liyan Chen

1.2k total citations
33 papers, 851 citations indexed

About

Liyan Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Liyan Chen has authored 33 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Liyan Chen's work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related Molecular Pathways (3 papers). Liyan Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related Molecular Pathways (3 papers). Liyan Chen collaborates with scholars based in China, United States and South Korea. Liyan Chen's co-authors include Zhenhua Lin, Jie Sun, Junjie Piao, Tiefeng Jin, Ming Xu, Xuelian Cui, Shuangping Liu, Qunying Wu, Yang� Yang and Yan Zhang and has published in prestigious journals such as PLoS ONE, Oncogene and British Journal of Cancer.

In The Last Decade

Liyan Chen

32 papers receiving 847 citations

Peers

Liyan Chen

ONCOL

PRM

Peng Zou China

Surojeet Sengupta United States

Virginie Poindessous France

Nengming Lin China

Xianping Shi China

Jayshree L. Hirpara Singapore

Nancy De Nève Belgium

Donghwa Kim South Korea

Samriddhi Shukla India

Peng Zou China

Liyan Chen

644 ×1.1

256 ×1.6

208 ×1.3

ONCOL

77 ×0.6

194 ×1.7

PRM

Citations per year, relative to Liyan Chen Liyan Chen (= 1×) peers Peng Zou

Countries citing papers authored by Liyan Chen

Since Specialization

Citations

This map shows the geographic impact of Liyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Chen more than expected).

Fields of papers citing papers by Liyan Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Chen. The network helps show where Liyan Chen may publish in the future.

Co-authorship network of co-authors of Liyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Chen. A scholar is included among the top collaborators of Liyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Chen. Liyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Mengying, et al.. (2025). β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1. Frontiers in Pharmacology. 16. 1509568–1509568. 2 indexed citations

Yan, Lijun, Xi Chen, Zhaolian Bian, et al.. (2022). A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma. Frontiers in Genetics. 13. 971364–971364. 8 indexed citations

Qiao, Dan, Jian Xing, Shiyu Wang, et al.. (2022). The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway. Phytomedicine. 100. 154046–154046. 23 indexed citations

Wang, Xinyue, et al.. (2022). The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability. Oncogene. 41(47). 5107–5120. 37 indexed citations

Zhu, Kun, et al.. (2021). [G6PC knockdown blocks AKT/mTOR pathway to inhibit proliferation, invasion and migration of cervical cancer HeLa cells].. PubMed. 37(6). 520–526.

Li, Nan, Jienan Kong, Zhenhua Lin, et al.. (2019). Ezrin promotes breast cancer progression by modulating AKT signals. British Journal of Cancer. 120(7). 703–713. 42 indexed citations

Piao, Junjie, Lianhua Zhu, Jie Sun, et al.. (2019). High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. Gene. 701. 15–22. 94 indexed citations

Zhu, Guang, et al.. (2019). <p>The prognostic value of Tiam1 correlates with its roles in epithelial–mesenchymal transition progression and angiogenesis in lung adenocarcinoma</p>. Cancer Management and Research. Volume 11. 1741–1752. 15 indexed citations

Xu, Ming, Tiefeng Jin, Liyan Chen, et al.. (2019). Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma. Gene. 696. 63–71. 30 indexed citations

10.

Chen, Liyan & Gang Su. (2019). Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma. BioMed Research International. 2019. 1–11. 15 indexed citations

11.

Li, Yue, et al.. (2018). Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer. OncoTargets and Therapy. Volume 11. 4367–4375. 15 indexed citations

12.

Piao, Junjie, et al.. (2017). Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker. Human Pathology. 73. 33–40. 21 indexed citations

13.

Yang, Yang, Meihua Gao, Zhenhua Lin, et al.. (2017). DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer. Oncotarget. 8(58). 98708–98722. 42 indexed citations

14.

Sun, Jie, et al.. (2017). Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. Oncology Letters. 13(5). 2996–3002. 17 indexed citations

15.

Sun, Jie, et al.. (2017). Mortalin overexpression predicts poor prognosis in early stage of non–small cell lung cancer. Tumor Biology. 39(3). 3726131191–3726131191. 31 indexed citations

16.

Chen, Liyan, et al.. (2016). The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast. Journal of Experimental & Clinical Cancer Research. 35(1). 42–42. 44 indexed citations

17.

Yang, Yang�, Yan Zhang, Qunying Wu, et al.. (2014). Clinical implications of high NQO1 expression in breast cancers. Journal of Experimental & Clinical Cancer Research. 33(1). 14–14. 147 indexed citations

18.

Chen, Liyan, et al.. (2014). High Expression of Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Predicts Poor Prognosis in Head and Neck Squamous Cell Carcinoma. BioMed Research International. 2014. 1–8. 9 indexed citations

19.

Chen, Liyan, Feng Ren, Tao Wen, et al.. (2012). Inhibition of Glycogen Synthase Kinase 3β Ameliorates D-GalN/LPS-Induced Liver Injury by Reducing Endoplasmic Reticulum Stress-Triggered Apoptosis. PLoS ONE. 7(9). e45202–e45202. 49 indexed citations

20.

Chen, Liyan, Kefang Lai, Jiaxing Xie, & Nanshan Zhong. (2010). Establishment of airway eosinophilic bronchitis mouse model without hyperresponsiveness by ovalbumin. Clinical and Experimental Medicine. 11(1). 19–24. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact